Doris Coleman

2.0k total citations
9 papers, 1.7k citations indexed

About

Doris Coleman is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Doris Coleman has authored 9 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 8 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Doris Coleman's work include Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (5 papers) and T-cell and B-cell Immunology (4 papers). Doris Coleman is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (5 papers) and T-cell and B-cell Immunology (4 papers). Doris Coleman collaborates with scholars based in United States and Spain. Doris Coleman's co-authors include Eli Gilboa, Johannes Vieweg, Donna Yancey, Jens Dannull, Donna Niedzwiecki, Axel Heiser, Philipp Dahm, Margaret A. Maurice, Costas D. Lallas and Zhen Su and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and Cancer Research.

In The Last Decade

Doris Coleman

9 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Doris Coleman United States	8	1.4k	883	771	257	92	9	1.7k
Donna Yancey United States	10	1.8k 1.3×	1.1k 1.3×	992 1.3×	299 1.2×	106 1.2×	12	2.2k
Remko Schotte Netherlands	14	1.4k 1.0×	468 0.5×	923 1.2×	133 0.5×	27 0.3×	23	1.8k
C H Delgado United States	8	1.5k 1.1×	755 0.9×	840 1.1×	251 1.0×	70 0.8×	8	1.9k
Sarah E. Townsend United States	9	1.8k 1.3×	548 0.6×	673 0.9×	305 1.2×	90 1.0×	9	2.1k
Beena O. Pappen United States	13	417 0.3×	560 0.6×	648 0.8×	226 0.9×	159 1.7×	19	1.1k
David Roulois France	13	641 0.5×	887 1.0×	439 0.6×	170 0.7×	28 0.3×	20	1.5k
Sarah L. Buchan United Kingdom	18	829 0.6×	392 0.4×	434 0.6×	102 0.4×	45 0.5×	26	1.1k
Elixabet Bolaños Spain	19	972 0.7×	290 0.3×	887 1.2×	146 0.6×	45 0.5×	33	1.4k
Felicia M. Rosenthal Germany	16	581 0.4×	317 0.4×	426 0.6×	308 1.2×	84 0.9×	35	893
Alex W. Tong United States	16	298 0.2×	644 0.7×	448 0.6×	464 1.8×	172 1.9×	26	1.2k

Countries citing papers authored by Doris Coleman

Since Specialization

Citations

This map shows the geographic impact of Doris Coleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doris Coleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doris Coleman more than expected).

Fields of papers citing papers by Doris Coleman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doris Coleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doris Coleman. The network helps show where Doris Coleman may publish in the future.

Co-authorship network of co-authors of Doris Coleman

This figure shows the co-authorship network connecting the top 25 collaborators of Doris Coleman. A scholar is included among the top collaborators of Doris Coleman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doris Coleman. Doris Coleman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Dahm, Philipp, et al.. (2006). In situ Activation of Dendritic Cells (DC) with Imiquimod for Cancer Immunotherapy. Cancer Research. 66. 941–941. 7 indexed citations

2.

Dannull, Jens, Zhen Su, Benjamin Yang, et al.. (2006). 398: Enhancement of Vaccine-Mediated Antitumor Immunity in Renal Cell Carcinoma (RCC) Patients after in vivo Depletion of Regulatory T Cells. Results from a Phase-I Clinical Trial. The Journal of Urology. 175(4S). 130–130. 2 indexed citations

3.

Su, Zhen, Jens Dannull, Benjamin Yang, et al.. (2005). Telomerase mRNA-Transfected Dendritic Cells Stimulate Antigen-Specific CD8+ and CD4+ T Cell Responses in Patients with Metastatic Prostate Cancer. The Journal of Immunology. 174(6). 3798–3807. 273 indexed citations

4.

Su, Zhen, Jens Dannull, Axel Heiser, et al.. (2003). Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells.. PubMed. 63(9). 2127–33. 285 indexed citations

5.

Heiser, Axel, Doris Coleman, Jens Dannull, et al.. (2002). Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors. Journal of Clinical Investigation. 109(3). 409–417. 23 indexed citations

6.

Heiser, Axel, Doris Coleman, Jens Dannull, et al.. (2002). Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors. Journal of Clinical Investigation. 109(3). 409–417. 419 indexed citations

7.

Heiser, Axel, Doris Coleman, Jens Dannull, et al.. (2002). Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors. Journal of Clinical Investigation. 109(3). 409–417. 382 indexed citations

8.

Heiser, Axel, Margaret A. Maurice, Donna Yancey, et al.. (2001). Human dendritic cells transfected with renal tumor RNA stimulate polyclonal T-cell responses against antigens expressed by primary and metastatic tumors.. PubMed. 61(8). 3388–93. 123 indexed citations

9.

Nair, Smita K., et al.. (1999). Induction of carcinoembryonic antigen (cea)-specific cytotoxic t-lymphocyte responsesIn vitro using autologous dendritic cells loaded with cea peptide or cea rna in patients with metastatic malignancies expressing cea. International Journal of Cancer. 82(1). 121–124. 141 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact